Daily pill doubles survival time for pancreatic cancer patients
**Health** ## Breakthrough Daily Pill Dramatically Extends Survival for Pancreatic Cancer Patients **A groundbreaking new daily oral medication, daraxonrasib, has demonstrated the ability to double the median survival time for a subset of patients battling advanced pancreatic cancer, according to results from a pivotal Phase 3 clinical trial. Hailed as a monumental stride against one
Daily pill doubles survival time for pancreatic cancer patients Read More »
Health